Sivik Global Healthcare
Latest statistics and disclosures from Sivik Global Healthcare's latest quarterly 13F-HR filing:
- Top 5 stock holdings are XBI, LLY, THC, NVO, UHS, and represent 31.46% of Sivik Global Healthcare's stock portfolio.
- Added to shares of these 10 stocks: XBI (+$30M), ABT (+$6.8M), MDT (+$5.4M), RVTY (+$5.1M), ZBH, STVN, ACHC, BAX, ASND, RGEN.
- Started 9 new stock positions in Put - Spy 100 @ 553 Exp 10/31/2024, ABT, ASND, XBI, ZBH, MDT, RVTY, Put - Spy 100 @ 565 Exp 10/31/2024, STVN.
- Reduced shares in these 10 stocks: Put - Spy 100 @ 545 Exp 07/19/2024 (-$55M), , TMO (-$7.7M), , RMD (-$5.7M), , , , DXCM, NTRA.
- Sold out of its positions in A, BIIB, BRKR, DXCM, EW, PODD, MEDP, MRK, NTRA, RMD. TMO, Put - Spy 100 @ 545 Exp 07/19/2024.
- Sivik Global Healthcare was a net seller of stock by $-54M.
- Sivik Global Healthcare has $236M in assets under management (AUM), dropping by -15.17%.
- Central Index Key (CIK): 0001596452
Tip: Access up to 7 years of quarterly data
Positions held by Sivik Global Healthcare consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Sivik Global Healthcare
Sivik Global Healthcare holds 35 positions in its portfolio as reported in the September 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Spdr S&p Biotech Etf S&p Biotech (XBI) | 12.5 | $30M | NEW | 300k | 98.80 |
|
| Eli Lilly & Co. (LLY) | 5.4 | $13M | -3% | 15k | 885.93 |
|
| Tenet Healthcare Com New (THC) | 4.6 | $11M | -7% | 65k | 166.20 |
|
| Novo-nordisk A/s Adr (NVO) | 4.5 | $11M | 90k | 119.07 |
|
|
| Univ Health Svc Class B (UHS) | 4.4 | $10M | +12% | 45k | 229.00 |
|
| McKesson Corporation (MCK) | 4.2 | $9.9M | +11% | 20k | 494.40 |
|
| Stryker Corporation (SYK) | 4.1 | $9.8M | +8% | 27k | 361.26 |
|
| Boston Scientific Corporation (BSX) | 3.7 | $8.8M | -8% | 105k | 83.80 |
|
| Intuitive Surg Com New (ISRG) | 3.6 | $8.6M | 18k | 491.26 |
|
|
| Danaher Corporation (DHR) | 3.5 | $8.3M | 30k | 278.03 |
|
|
| Hca Holdings (HCA) | 3.4 | $8.1M | -20% | 20k | 406.45 |
|
| Surgery Partners (SGRY) | 3.1 | $7.4M | -8% | 230k | 32.24 |
|
| Acadia Healthcare (ACHC) | 3.1 | $7.3M | +43% | 115k | 63.41 |
|
| Abbott Laboratories (ABT) | 2.9 | $6.8M | NEW | 60k | 114.02 |
|
| Avantor (AVTR) | 2.7 | $6.5M | 250k | 25.87 |
|
|
| Becton, Dickinson and (BDX) | 2.6 | $6.0M | 25k | 241.12 |
|
|
| Baxter International (BAX) | 2.4 | $5.7M | +50% | 150k | 37.97 |
|
| AmerisourceBergen (COR) | 2.4 | $5.6M | -3% | 25k | 225.08 |
|
| Medtronic SHS (MDT) | 2.3 | $5.4M | NEW | 60k | 90.03 |
|
| PerkinElmer (RVTY) | 2.2 | $5.1M | NEW | 40k | 127.75 |
|
| West Pharmaceutical Services (WST) | 2.2 | $5.1M | +30% | 17k | 300.18 |
|
| Cardinal Health (CAH) | 2.1 | $5.0M | -25% | 45k | 110.51 |
|
| Select Medical Holdings Corporation (SEM) | 2.1 | $4.9M | -3% | 140k | 34.87 |
|
| Encompass Health Corp (EHC) | 2.0 | $4.8M | -9% | 50k | 96.64 |
|
| Vertex Pharmaceuticals Incorporated (VRTX) | 2.0 | $4.7M | -33% | 10k | 465.10 |
|
| Smith & Nephew Spdn Adr New (SNN) | 1.8 | $4.4M | -6% | 140k | 31.14 |
|
| Zimmer Holdings (ZBH) | 1.8 | $4.3M | NEW | 40k | 107.95 |
|
| Repligen Corporation (RGEN) | 1.6 | $3.7M | +66% | 25k | 148.84 |
|
| Maravai Lifesciences Hldgs-a Com Cl A (MRVI) | 1.5 | $3.5M | -5% | 425k | 8.31 |
|
| Humana (HUM) | 1.3 | $3.2M | +33% | 10k | 316.70 |
|
| Teva Pharm Sponsored Ads (TEVA) | 1.3 | $3.1M | -15% | 170k | 18.02 |
|
| Stevanato Group S P A (STVN) | 1.2 | $2.8M | NEW | 140k | 20.00 |
|
| Ascendis Pha- Sponsored Adr (ASND) | 0.6 | $1.5M | NEW | 10k | 149.30 |
|
| Put - Spy 100 @ 565 Exp 10/31/2024 Put Put Option | 0.4 | $861k | NEW | 1.5k | 574.00 |
|
| Put - Spy 100 @ 553 Exp 10/31/2024 Put Put Option | 0.3 | $746k | NEW | 1.3k | 573.85 |
|
Past Filings by Sivik Global Healthcare
SEC 13F filings are viewable for Sivik Global Healthcare going back to 2013
- Sivik Global Healthcare 2024 Q3 filed Nov. 6, 2024
- Sivik Global Healthcare 2024 Q2 filed July 29, 2024
- Sivik Global Healthcare 2024 Q1 filed May 1, 2024
- Sivik Global Healthcare 2023 Q4 filed Feb. 5, 2024
- Sivik Global Healthcare 2023 Q3 filed Nov. 7, 2023
- Sivik Global Healthcare 2023 Q2 filed Aug. 9, 2023
- Sivik Global Healthcare 2023 Q1 filed May 8, 2023
- Sivik Global Healthcare 2022 Q4 filed Feb. 8, 2023
- Sivik Global Healthcare 2022 Q3 filed Nov. 4, 2022
- Sivik Global Healthcare 2022 Q2 filed Aug. 10, 2022
- Sivik Global Healthcare 2022 Q1 filed May 9, 2022
- Sivik Global Healthcare 2021 Q4 filed Feb. 8, 2022
- Sivik Global Healthcare 2021 Q3 filed Nov. 12, 2021
- Sivik Global Healthcare 2021 Q2 filed Aug. 10, 2021
- Sivik Global Healthcare 2021 Q1 filed May 12, 2021
- Sivik Global Healthcare 2020 Q4 filed Feb. 16, 2021